McAdam LLC’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.61M | Buy |
3,921
+331
| +9% | +$336K | 0.16% | 79 |
|
|
2025
Q4 | $3.86M | Buy |
3,590
+69
| +2% | +$66K | 0.18% | 71 |
|
|
2025
Q3 | $2.69M | Buy |
3,521
+264
| +8% | +$196K | 0.13% | 85 |
|
|
2025
Q2 | $2.54M | Buy |
3,257
+2
| +0.1% | +$1.55K | 0.14% | 79 |
|
|
2025
Q1 | $2.69M | Sell |
3,255
-122
| -4% | -$102K | 0.17% | 76 |
|
|
2024
Q4 | $2.61M | Buy |
3,377
+227
| +7% | +$188K | 0.14% | 81 |
|
|
2024
Q3 | $2.79M | Buy |
3,150
+181
| +6% | +$163K | 0.16% | 77 |
|
|
2024
Q2 | $2.69M | Buy |
2,969
+523
| +21% | +$418K | 0.16% | 73 |
|
|
2024
Q1 | $1.9M | Buy |
2,446
+856
| +54% | +$609K | 0.12% | 85 |
|
|
2023
Q4 | $927K | Buy |
1,590
+84
| +6% | +$49K | 0.07% | 120 |
|
|
2023
Q3 | $809K | Buy |
1,506
+188
| +14% | +$96.9K | 0.07% | 124 |
|
|
2023
Q2 | $618K | Buy |
1,318
+390
| +42% | +$164K | 0.05% | 138 |
|
|
2023
Q1 | $319K | Sell |
928
-23
| -2% | -$7.76K | 0.03% | 193 |
|
|
2022
Q4 | $263K | Buy |
951
+72
| +8% | +$25.5K | 0.03% | 157 |
|
|
2022
Q3 | $284K | Buy |
879
+25
| +3% | +$7.92K | 0.03% | 172 |
|
|
2022
Q2 | $277K | Sell |
854
-26
| -3% | -$7.8K | 0.03% | 184 |
|
|
2022
Q1 | $252K | Sell |
880
-71
| -7% | -$18.3K | 0.02% | 178 |
|
|
2021
Q4 | $263K | Buy |
951
+31
| +3% | +$7.86K | 0.03% | 157 |
|
|
2021
Q3 | $213K | Buy |
920
+31
| +3% | +$7.65K | 0.02% | 166 |
|
|
2021
Q2 | $218K | Buy |
+889
| New | +$179K | 0.02% | 159 |
|
|
2018
Q4 | – | Sell |
-174
| Closed | -$19K | – | 376 |
|
|
2018
Q3 | $19K | Hold |
174
| – | – | 0.01% | 264 |
|
|
2018
Q2 | $15K | Hold |
174
| – | – | 0.01% | 286 |
|
|
2018
Q1 | $13K | Buy |
+174
| New | +$14K | 0.01% | 303 |
|
Other funds holding LLY
VCM
VPM
